However, miR-26a on one hand and p35 on the other might respectively regulate or be regulated by other genes as well, thereby further studies might be needed in order to finally evaluate their potentiality as novel prognostic markers and/or potential therapeutic targets for DLBCL. Here, CDK5R1 is linked to diffuse large B-cell lymphoma.